India and Oman Pharmaceutical Industry Market Analysis
The pharmaceutical market comprises deals of pharmaceuticals and related administrations by substances (associations, sole merchants, and organizations) that produce pharmaceuticals utilized in treating diseases like diabetes, malignant growth, cardiovascular disease, ongoing and kidney issues, and others. Pharmaceuticals can be any type of medicines that are utilized for therapeutic purposes, in the treatment of diseases. This industry incorporates associations or organizations that create pharmaceutical and biologics drugs. Pharmaceutical organizations are offering drugs for redid individual treatment for different diseases as recorded previously. Customized medication, likewise alluded to as accuracy medication, intends to give clinical consideration as per the patient’s singular attributes and hereditary cosmetics. Accuracy therapies are progressively being taken on as firms progressively let go of the one-size-fits-all model for normal ailments like a cellular breakdown in the lungs, melanoma (skin malignant growth), colon disease, and pancreatic malignant growth. It can likewise assist with some intriguing youth sicknesses, cystic fibrosis, and HIV.
Expanding number of item dispatches in the India pharmaceutical industry is relied upon to drive the market development over the estimated time frame.
The rising number of item dispatches in the India pharmaceutical industry is relied upon to drive the development of the India pharmaceutical industry market over the gauge time frame. For example, in February 2021, Glenmark Pharmaceuticals, a pharmaceutical organization in India, reported the send-off of SUTIB, a generic rendition of Sunitinib oral cases showed for the therapy of kidney malignant growth in India.
๐๐๐ญ ๐๐๐๐๐ฌ๐ฌ ๐จ๐ ๐๐ฎ๐ญ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: @ https://www.coherentmarketinsights.com/insight/request-sample/4569
The rising pervasiveness of constant diseases in Oman is relied upon to drive the market development over the figure time frame.
For example, as indicated by The Ministry of Health (MOH) report 2017, the number of recorded cancer cases in 2017 came to 2,101 including 1,892 (90.05%) cases among Omanis, 188 (8.95%) cases among inhabitants, and 19 (0.9%) instances of Carcinoma in situ among Omanis. Furthermore, as per the comparative source, the number of disease cases among Omani guys came to 887 (46.9%) contrasted with 1,005 (53.1%) cases among Omani females. 127 (6.7%) cases were enlisted among Omani kids at 14 years old and under in 2017.
India and Oman Pharmaceutical Industry market-Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 infection episode in December 2019, the disease has spread to over 100 nations across the globe and the World Health Organization announced it a general wellbeing crisis in 2020. As indicated by the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, the quantity of COVID-19 cases detailed in India as of July 8, 2021, are roughly 30,663,665 affirmed cases and 404,211 passings. Moreover, as per a similar source, the quantity of COVID-19 cases revealed in Oman as of July 8, 2021, is around 278,560 affirmed instances of COVID-19 and 3,339 passings. The significant difficulties faced by vital participants incorporate stock of unrefined components expected for assembling instruments and reagent packs because of abnormalities in the transportation office, sporadic demand for items from the retailers because of expanding number of patients experiencing COVID-19 and other dangerous disorders.
Along these lines, to overcome the reliance on dynamic pharmaceutical fixing (API) and unrefined substances, the Indian government is centered around creating and assembling unrefined components and dynamic pharmaceutical fixings. For example, in 2020, the government of India reported the motivating force bundle of INR 13.76 billion (US$ 18.39 Bn) for the advancement of homegrown assembling of basic key beginning materials, drug intermediates, APIs, and clinical gadgets in India. Moreover, as indicated by the Directorate-General of Pharmacy and Drug Control Oman 2020, in Oman there was a restriction on the commodity of veils, hand sanitizers, and clinical inventory items to the other nations because of deficiency of the pharmaceutical apparatuses and items in Oman.
๐๐๐๐๐ข๐ฏ๐ ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/4569
India and Oman Pharmaceutical Industry Market: Restraint
A large number of restricted items in India and the absence of public medical coverage plans in Oman are relied upon to frustrate the development of the India and Oman pharmaceutical industry market. For example, as per the Central Drugs Standard Control Organization and Directorate General of Health Services Ministry of Health and Family Welfare Government of India, restricted drugs in 2018 incorporate blends of Nimesulide + Levocetrizine, Ofloxacin + Ornidazole Injection and Glucosamine + Ibuprofen because of their aftereffects and drug misuse circumstances. While, the absence of public medical coverage plan in Oman prompts the costs of the public medical services system to be relied upon by the government, propagating dependence on state arrangements and stressing the government spending plan and is relied upon to frustrate the development of the market.
Vital participants
Key players working in the India and Oman pharmaceutical industry market incorporate Unichem Laboratories, Strides Pharma Science Limited, Biocon Limited, Serum Institute, Sun Pharmaceutical Industries Limited, Lupin Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Eli Lilly and Company, GlaxoSmithKline plc, AbbVie, Merck & Co., Inc., Novartis International AG, Bayer AG, F. Hoffmann-La Roche AG, Sanofi S.A., Bristol Myers Squibb, and Pfizer, Inc.ย
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐ @ https://www.coherentmarketinsights.com/promo/buynow/4569
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Country
- Market Opportunity Map
- Report Description
- India & Oman Pharmaceutical Industry Market
- Analysis of the Indian Pharmaceutical Industry
- Drivers & Restraints
- Market Opportunity
- Market Trends
- Impact Analysis
- Mergers and Acquisitions
- Epidemiology
- PEST Analysis
- SWOT Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Major Indian Exporters/Manufacturers (Global)
- Major Indian Importers
- Major Indian Exporters/Manufacturers (To Oman)
- Indian Pharmaceutical Drugs Import Market
- Indian Pharmaceutical Drugs Export Market
- Indian Pharmaceutical Drugs Export to Oman Market
- Analysis of the Oman Pharmaceutical Industry
- Drivers & Restraints
- Market Opportunity
- Market Trends
- Impact Analysis
- Mergers and Acquisitions
- Epidemiology
- PEST Analysis
- SWOT Analysis
- Regulatory Scenario
- Industry Regulations
- Trade Regulations and Procedures For Export to Oman
- Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
- Reimbursement Scenario
- Major Oman Exporters/Manufacturers (Global)
- Major Oman Importers
- Strategy For Indian Pharma Products In Oman
- India’s Strategy For Effectively Entering Oman Pharma Market
- USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
- Oman Pharmaceutical Drugs Import Market
- Oman Pharmaceutical Drugs Export Market
- Oman Pharmaceutical Drugs Export to India Market
- Ayurvedic Drugs Market
- Overview of Indian Ayurvedic Drugs
- Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
- Overview of Oman Ayurvedic Drugs Import
- Indian Ayurvedic Companies Registered in Oman
- Strategies Adopted By Local Oman Manufacturers
- Analysis of the Indian Pharmaceutical Industry
- India & Oman Pharmaceutical Industry Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact of COVID-19 on Pharmaceutical Market
- Demand and Supply Chain Analysis
- Government Initiative
- India & Oman Pharmaceutical Industry Market, By Drug, 2011 โ 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2030 (%)
- Y-o-Y Growth Analysis, 2012 โ 2030
- Segment Trends
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Patented (Branded)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Introduction
- India & Oman Pharmaceutical Industry Market, By Type, 2011 โ 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2030 (%)
- Y-o-Y Growth Analysis, 2012 โ 2030
- Segment Trends
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Over the Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million
- Introduction
- India & Oman Pharmaceutical Industry Market, By Drug Class, 2011 โ 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2030 (%)
- Y-o-Y Growth Analysis, 2012 โ 2030
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Antibacterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- ACE inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Hormonal agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Introduction
- India & Oman Pharmaceutical Industry Market, By Application, 2011 โ 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2030 (%)
- Y-o-Y Growth Analysis, 2012 โ 2030
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Ischemic Heart Disease
- Others
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Metabolic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Diabetes
- Others
- Weight Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Genito-urinary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Kidney Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Others (Nutraceutical, Dentals, and Gynecology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Introduction
- India & Oman Pharmaceutical Industry Market, By Distribution Channel, 2011 โ 2030 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2030 (%)
- Y-o-Y Growth Analysis, 2012 โ 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2011 โ 2030 (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/india-and-oman-pharmaceutical-industry-market-3811
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837